United States· US:83257-009_bd1edac2-0e84-e635-7bef-e167ba08ed0d
JOBEVNE
A medicinal product containing bevacizumab, registered in United States by Biocon Biologics Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BEVACIZUMAB
- Manufacturer
- Biocon Biologics Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 2
- ndc1183257009111 VIAL, SINGLE-DOSE in 1 CARTON (83257-009-11) / 4 mL in 1 VIAL, SINGLE-DOSE
- ndc1183257-009-11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bevacizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAbevmy 100mg/4ml concentrate for solution for infusion vialsBiocon Biologics Ireland Ltd
- CzechiaABEVMYBiosimilar Collaborations Ireland Limited, Dublin
- BelgiumAbevmy 25 mg/mlBiosimilar Collaborations Ireland
- FinlandAbevmyBiosimilar Collaborations Ireland Limited
- SwitzerlandAbevmy
- SpainABEVMY 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONBiosimilar Collaborations Ireland Limited
- CanadaABEVMYBIOSIMILAR COLLABORATIONS IRELAND LIMITED
- PolandAbevmyBiosimilar Collaborations Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Oyavas
- Iceland · Abevmy, Alymsys
- Liechtenstein · Abevmy, Alymsys
- Norway · Abevmy, Alymsys
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3ce6bee-6e61-46ea-8ebd-70b2b7371737 GET /v1/drugs/b3ce6bee-6e61-46ea-8ebd-70b2b7371737?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVASCULAR",
"source": "ndc",
"strength": "25",
"substance": "BEVACIZUMAB",
"productndc": "83257-009",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761175",
"marketing_category": "BLA"
}See everything about bevacizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.